Innovative research is being performed in universities worldwide. There is a quest for knowledge, glory, and most importantly, helping the sick. On...

The San Diego Business Journal recently interviewed Scientist’s CEO Kevin Lustig about his latest side venture: “Bio, Tech and Beyond”, which is a...

We work with researchers from big and large pharma to discover new CROs and outsource drug discovery. Whether they have worked with a handful of...

As previously discussed, drug development costs have been rising to almost prohibitive levels. In 1975, the average approved drug cost $100 million...

Outsourcing a project is often seen as an all or nothing proposition: either an entire project is outsourced or everything is kept in house. The...

This is Part 1 in a four-part series in which Dr. Kevin Lustig and Dr. Maria Thompson explore a new paradigm for virtual drug discovery in a...

You’ve made the decision to outsource to a contract research organization, but you’re not sure where to start. Do you send it overseas for lower...

We found this on twitter today. It appears @mrgunn doesn’t really grasp the bigger picture of what we do if he thinks of @scientist_com as “just...

In two compelling presentations at the Bio-IT World Conference last week, Atul Butte and Steven Salzberg provided formidable advocacy for the...

The health and behavior of each one of our cells is influenced by both genetics and epigenetics. Drug discovery has historically targeted proteins...